NCT07467694 Postnatal Exercise to Activate Baby's Brown Fat
| NCT ID | NCT07467694 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Joslin Diabetes Center |
| Condition | Childhood Obesity Prevention |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2025-12-01 |
| Primary Completion | 2030-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2025-12-01 with a primary completion date of 2030-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to learn how exercise and physical activity during pregnancy and after pregnancy may affect the composition of breastmilk. Certain changes in breast milk after exercise may have an impact on how infants use energy. Understanding this process may improve public health recommendations for exercise during and after pregnancy. This study can help investigators learn more about how maternal exercise patterns may affect body growth and obesity risk in infants who are breastfed. This research may help identify how different factors can influence healthy weight and early development in infants.
Eligibility Criteria
Inclusion Criteria: * 18-45 y of age at the time of enrollment * Pre-gravid or first trimester BMI 18.5 -40 kg/m2 * Uncomplicated singleton pregnancy * Intention to exclusively breastfeed for \>3 months and, if parity \>1, that they successfully breastfed a previous pregnancy * Term pregnancy (gestational age 37 to \<42 weeks) * Infant with birth weight \>10th percentile of weight for gestational age Exclusion Criteria: * Any obstetric contra-indication to exercise at 1 month * Diagnosis of uncontrolled (HbA1c \>7%) type 1 or type 2 diabetes, or gestational diabetes managed with insulin * Intrauterine growth restriction * Pre-eclampsia or other pregnancy complications * Alcohol, cannabis or tobacco use * Known congenital metabolic, endocrine disease, or congenital illness affecting infant feeding/growth * Major fetal anomalies * Musculoskeletal issues that would make exercise difficult
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07467694 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 45 Years, studying Childhood Obesity Prevention. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07467694 currently recruiting?
Yes, NCT07467694 is actively recruiting participants. Contact the research team at elvira.isganaitis@joslin.harvard.edu for enrollment information.
Where is the NCT07467694 trial being conducted?
This trial is being conducted at Boston, United States, Oklahoma City, United States.
Who is sponsoring the NCT07467694 clinical trial?
NCT07467694 is sponsored by Joslin Diabetes Center. The trial plans to enroll 200 participants.
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.